-
Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Consensus Rating of "Hold" from Analysts
Source: Buzz FX / 18 Oct 2024 05:22:13 America/New_York
Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Consensus Rating of "Hold" from Analysts Written by MarketBeat October 18, 2024 Share Link copied to clipboard. Shares of Revance Therapeutics, Inc. ( NASDAQ:RVNC - Get Free Report ) have re
Read more...